Neuronetics, Inc. officer Cory Anderson filed a Form 144 notice on November 10, 2026, disclosing a proposed sale of 5,137 shares of common stock through Fidelity Brokerage Services LLC on NASDAQ.

Key Highlights

  • Seller: Cory Anderson, identified in the filing as an officer of Neuronetics, Inc.
  • Shares proposed for sale: 5,137 shares of common stock, with an aggregate market value of $10,654.65 according to the filing.
  • Source of shares: The shares were acquired on September 30, 2026, through restricted stock vesting from the issuer, with payment classified as compensation.
  • Shares outstanding: The filing reports 77,728,311 shares of common stock outstanding.
  • No prior sales reported: The filing indicates nothing to report for securities sold during the past three months.
  • Tax-related purpose noted: The filing states that the "sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution."

Neuronetics Officer Files Rule 144 Notice for November 2026 Restricted Stock Sale

According to the filing, Cory Anderson, an officer of Neuronetics, Inc. (NASDAQ:STIM), submitted a Form 144 notice dated November 10, 2026, proposing to sell 5,137 shares of the company's common stock. The proposed sale is to be executed through Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, Rhode Island 02917, on the NASDAQ exchange on approximately November 10, 2026.

The filing discloses that the 5,137 shares were acquired on September 30, 2026, via restricted stock vesting from the issuer, Neuronetics, Inc., with the nature of payment described as compensation. The aggregate market value of the shares proposed for sale is listed as $10,654.65. As of the filing date, the company reported 77,728,311 total shares of common stock outstanding.

The filing includes a remark stating that the "sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution." The Form 144 was signed by Joshua Schmitt as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Cory S. Anderson. The filing further notes that Anderson reported no sales of Neuronetics securities during the three months preceding the notice.

What Was Disclosed

Neuronetics officer Cory Anderson filed a Rule 144 notice proposing to sell 5,137 shares of common stock acquired through restricted stock vesting on September 30, 2026, with the stated purpose of covering a tax obligation related to a vested equity award.